Aplagon Oy
EIC Accelerator Winner From 2022
APAC – the first targeted therapy for peripheral arterial occlusive disease.
Finland
Articles
EIC Accelerator Funding Boosts Aplagon Oy's Development of Innovative PAOC Treatment
FinlandEIC Accelerator2022
Read Article